Antral follicle count and anti-Mullerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients
HUMAN REPRODUCTION, cilt.36, sa.6, ss.1530-1541, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 36 Sayı: 6
- Basım Tarihi: 2021
- Doi Numarası: 10.1093/humrep/deab056
- Dergi Adı: HUMAN REPRODUCTION
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.1530-1541
- Anahtar Kelimeler: assisted reproductive technology, antral follicle count, anti-Mullerian hormone, POSEIDON criteria, agreement study, low prognosis, poor 90 response, IVF/ICSI, CONTROLLED OVARIAN STIMULATION, ANTIMULLERIAN HORMONE, INTEROBSERVER RELIABILITY, 3-DIMENSIONAL ULTRASOUND, ANTAGONIST PROTOCOL, PREDICTION, RESERVE, VARIABILITY, INTRAOBSERVER, CYCLE
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Hacettepe Üniversitesi Adresli: Evet
Özet
STUDY QUESTION: What is the agreement between antral follicle count (AFC) and anti-Mullerian hormone (AMH) levels when used to patient classification according to the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria?